EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Effect of Repetitive Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex on the Amyotrophic Lateral Sclerosis Patients With Cognitive Impairment: A Double‐Blinded, Randomized, and Sham Control Trial

Wensi Zheng, Xiaojie Zhang, Jingjiong Chen, Xinghua Luan, Jijun Wang, Liren Zhang, Kun Liu, Yuwu Zhao, Zhouwei Xu iD

CNS Neuroscience & Therapeutics · 2025

DOI: 10.1111/cns.70316 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Wensi Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Transcranial Magnetic Stimulation, Cognitive Dysfunction, Dorsolateral Prefrontal Cortex. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Sailing program, Shanghai Science and Technology Innovation Action Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. A large number of ALS patients have cognitive impairment. In this double‐blinded, randomized, and sham‐controlled study, we aimed to investigate the effect of repetitive transcranial magnetic stimulation (rTMS) on ALS patients with cognitive impairment.

Methods

A total of 90 ALS patients with cognitive impairment were recruited from two cohorts; 80 participants were randomly assigned in a 1:1 ratio to receive 10 Hz rTMS or sham treatment on the bilateral dorsolateral prefrontal cortices (DLPFC) for 4 consecutive weeks. The patients were assessed by ECAS and ALSFRS‐R scales. The Zarit care burden scale was administered to caregivers of ALS patients. The primary outcome measured was the rate of decline in the total ECAS score between pretreatment, 6 months post‐treatment, and 12 months post‐treatment. Secondary outcomes included the group difference in the slope of the Zarit score, ALSFRS‐R total score, and the neurofilament light chain plasma levels.

Results

The ECAS total score in the intention‐to‐treat population significantly changed from 79.74 ± 6.39 to 81.98 ± 6.51 and 79.22 ± 6.50 with rTMS intervention at the 6‐month and 12‐month follow‐ups, respectively ( p = 0.031, p = 0.042). The Zarit score also significantly decreased from 57.65 ± 3.42 to 52.24 ± 3.34 and 56.42 ± 3.41 at the 3‐month and 6‐month post‐treatment time points, respectively ( p = 0.003, p = 0.014). No significant differences were observed between the groups for other secondary endpoints. However, there was a trend of decreasing NF‐L level rates in the treatment group over the first 6 months' follow‐up. Conclusions rTMS could yield short‐term positive effects on the ALS patients subgroup with cognitive impairment and alleviate caregivers' burden. No improvement was observed in the severity of ALS and ALS plasma biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisTranscranial Magnetic StimulationCognitive DysfunctionDorsolateral Prefrontal CortexPrefrontal CortexHumansDouble-Blind MethodMaleFemaleMiddle AgedAgedTreatment OutcomeAdult

Stichwörter der Autor:innen

amyotrophic lateral sclerosiscaregiver's burdencognitive impairmentprognosistranscranial magnetic stimulation

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Neurology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Neurological Rare Disease Biobank and Precision Diagnostic Technical Service Platform, Shanghai, China.
  • Department of Rehabilitation Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Zhouwei Xu

Förderung

  • Shanghai Sailing program
  • Shanghai Science and Technology Innovation Action Plan

Zitieren

APA

Zheng, W., Zhang, X., Chen, J., Luan, X., Wang, J., Zhang, L., Liu, K., Zhao, Y., & Xu, Z. (2025). The Effect of Repetitive Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex on the Amyotrophic Lateral Sclerosis Patients With Cognitive Impairment: A Double‐Blinded, Randomized, and Sham Control Trial. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70316

Vancouver

Zheng W, Zhang X, Chen J, Luan X, Wang J, Zhang L, et al. The Effect of Repetitive Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex on the Amyotrophic Lateral Sclerosis Patients With Cognitive Impairment: A Double‐Blinded, Randomized, and Sham Control Trial. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70316

BibTeX
@article{Zheng2025,
  author = {Zheng, Wensi and Zhang, Xiaojie and Chen, Jingjiong and Luan, Xinghua and Wang, Jijun and Zhang, Liren and Liu, Kun and Zhao, Yuwu and Xu, Zhouwei},
  title = {The Effect of Repetitive Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex on the Amyotrophic Lateral Sclerosis Patients With Cognitive Impairment: A Double‐Blinded, Randomized, and Sham Control Trial},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  doi = {10.1111/cns.70316}
}
Kostenlos starten →